SUMMARY Sera from 48 infertile women with tubal pathology and from 77 infertile women with normal fallopian tubes were tested by enzyme linked immunosorbent assay (ELISA) using Chlamydia trachomatis and Neisseria gonorrhoeae antigens. Control sera were obtained from women undergoing abortion, sterilisation, and from women practising barrier contraception. The results of ELISA for antibodies to chlamydiae were in close agreement with results published previously of an immunofluorescence test on these sera.8 Antibodies to Ctrachomatis were found in 73% of the infertile women with tubal pathology, significantly more than in any of the control groups. Only a very low prevalence (2-5%) of antibodies to gonococcal pili was found in all groups, except women undergoing abortion (16%).
Several studies have established the importance of Chlamydia trachomatis in the aetiology of infertility due to tubal occlusion following salpingitis.' 2 The relative importance of Neisseria gonorrhoeae as opposed to C trachomatis in this process has been less extensively investigated, particularly in the United Kingdom. Studies in southern Sweden and France indicate that gonococci or mycoplasma are a less common cause of salpingitis, and by implication, of infertility, than are chlamydiae.34 In Holland, however, a serological study suggested that gonococci were a more common cause of infertility with tubal dysfunction than were chlamydiae.5 In The Gambia in West Africa both gonococci and C trachomatis are highly prevalent in sexually active urban populations, 6 and serological studies indicate that these organisms are of similar importance in the aetiology of infertility following tubal occlusion. 7 Conway et al,8 using a whole inclusion immunofluorescence test (WIF),9 showed circulating antibodies to C trachomatis in 36 of 48 infertile women with damaged tubes, 23 of 75 infertile women with normal tubes, and 17 of 72 normal women using barrier contraception in Bristol. The present paper describes the results of a collaborative study performed on these Bristol sera with two main objectives.
Accepted for publication 9 October 1986 Firstly, to determine the importance of gonococci in the aetiology of tubal infertility in the United Kingdom by measuring the prevalence of gonococcal antibody, and secondly, to determine in two independent laboratories the comparative merits of enzyme linked immunosorbent assay (ELISA) and WIF as screening procedures for the serological identification of past or present chlamydial infection.
Patients and methods
Blood samples were collected from 48 infertile patients with tubal pathology and from 77 infertile patients with normal fallopian tubes ( Sera were given a numerical code so that the clinical condition of the patient was unknown to the laboratories measuring chlamydial antibody. In Bristol antibodies were measured by immunofluorescence using cells infected with C trachomatis L2 as antigen and in Southampton by ELISA using purified elementary bodies from C trachomatis LI. 4 shows the percentage of patients with a given level of antibody to chlamydiae (measured by WIF or ELISA) and to gonococcal pili for each of the clinical categories examined. On the basis of these frequency distributions, sera having a WIF titre of > 1/32 or an ELISA area of > 10 were regarded as positive for chlamydial antibody. An ELISA area of > 9 was regarded as positive for antibody to gonococcal pili. Table 2 shows the prevalence of antibody in each of 379 Data not available for all patients. tNot significant.
Primary infertility was defined as failure to conceive. Secondary infertility was infertility developing subsequent to an initial pregnancy. There was a significantly increased prevalence of chlamydial but not gonococcal antibody in infertile women with tubal pathology compared with that in infertile women with normal tubes.
ilisation, termination of pregnancy, or using barrier contraception was 19 6, 14-1, 16-4, 17 3, and 18 7, respectively indicating little difference in the level of antibody among positive sera in these groups. Table 3 shows the prevalence of chlamydial antibody in sera from infertile women with either primary or secondary infertility. There was no significant difference between the prevalence of antibody to Ctrachomatis in women with tubal pathology with either primary or secondary infertility. In infertile women with normal tubes, however, there was an increase in the prevalence of sera with chlamydial antibody in cases of secondary infertility. The mean antibody level, calculated from the area under the curve, was greater in positive sera from infertile women with tubal pathology than in positive sera from infertile women with normal tubes. There was no significant difference between level of antibody response according to whether these women were suffering from primary or secondary infertility. 36' t27. Studies in Scandinavia, France, Holland and the United Kingdom have documented an association between infertility with tubal pathology and the presence of circulating antibody to C trachomatis. The results reported here confirm the findings of Conway et al8 on the same group of patients, supporting the concept of C trachomatis as a major cause of tubal damage and resultant infertility in the United Kingdom. Less information is available on the importance of gonococci in the aetiology of tubal infertility.
Gonococcal infection results in persistent circulating
IgG antibody to gonococcal pili.'4 Pilus structure is hypervariable as a result of gene reassortment"5; nevertheless, the human immune response includes Antibodies in infertile women with tubal obstruction antibody to a common immunodeterminant present on different gonococcal pili.'6 Thus-pili have been regarded as an excellent and specific antigen for the serological detection of gonococcal infection."4 The presence of persistent IgG antibody for both gonococci and chlamydiae as an indicator of past infection is of major importance in establishing the aetiology of tubal infertility, as, by the time infertility has become apparent, the acute genital tract infection will have usually resolved. The measurement of serum IgA titre against chlamydiae, however, did not improve the discrimination between sera from infertile and fertile women (fig 5) , although it has been reported to be useful in the diagnosis of acute chlamydial infections, including salpingitis."7 IgM antibody to chlamydiae is rarely found in acute salpingitis."8
The prevalence of gonococcal antibody in infertile women and in women using barrier contraception or seeking sterilisation in this study was only 2-5%. This low prevalence of antibody is consistent with a low cumulative rate of gonococcal infection in these women. Ten of 63 Bristol women (16%) seeking termination of pregnancy, however, had antibody to gonococcal pili, suggesting that this group had a higher rate of gonococcal infection.
Overall, the data suggest that in the United Kingdom (Bristol) chlamydiae, rather than gonococci, are the most identified cause of tubal infertility. This finding is in agreement with data from Sweden3 and Denmark, '8 19 but is at variance with results from Holland.5 In that study gonococcal and chlamydial antibody was found in 60% and 21%, respectively, of infertile women with tubal pathology but was absent from blood donors and children presumed not to have experienced gonococcal infection. Gonococcal antibody was found in 25% of infertile women with normal tubes, an unexpected result in view of the absence of antibody in control blood donor sera investigated by the same group. The reason for this difference in the aetiology of tubal infertility between Scandinavia and the United Kingdom on the one hand and Holland on the other is not clear.
In developing countries gonococci may be a more important cause of tubal infertility than in the United Kingdom. Using similar serological techniques in The Gambia, we observed that both gonococcal and chlamydial antibody were significantly associated with tubal infertility compared with that of matched fertile controls.7 The importance of gonococci in West Africa but not the United Kingdom in the aetiology of tubal fertility can be explained by the high level of carriage of both organisms in Gambian women,6 the four-fold increased proportion of overall infertility associated with infection in Africa,'3 the increased contribution of chlamydiae to sexually transmitted disease in the United Kingdom, and the Robertson, Ward, Conway, Caul greater likelihood that the more florid gonococcal salpingitis would be promptly treated in the United Kingdom.
Our findings have shown an association between infertility due to tubal obstruction and serological evidence of a history of chlamydial infection. Clearly it would be desirable if serology could be used in conjunction with other tests to establish the presence of chlamydial infection when the patient presents with pelvic inflammatory disease. This would permit the use of antichlamydial chemotherapy prior to the development of infertility, might obviate unnecessary and expensive investigation of the patient, and could provide data on the success of local sexually transmitted disease clinic control measures. Technically, ELISA offers a simple method of screening large numbers of patients for chlamydial antibody. Sera can be screened at a single dilution as shown by the high correlation (r = 0 929 for the tubal pathology group) of OD4sonm at a 1/100 dilution of serum for IgG with the integrated titration curve. Moreover, the close agreement observed between the results of the ELISA and immunofluorescence tests in this study suggests that the tests were measuring similar antibodies. By comparison with immunofluorescence, ELISA is far less tedious for screening large numbers of sera, can be more objectively quantitated, and permits ready automation. The high titres of chlamydial (but not gonococcal) antibody by ELISA and WIF in control women using barrier contraception may result from previous infection with chlamydiae or might be due to antibody to other organisms cross reacting with chlamydial antigens. Essentially similar results were obtained irrespective of whether the ELISA was performed with whole C trachomatis elementary bodies or with purified outer membrane complex derived from them (data not shown).
In one study of acute salpingitis confirmed by laparoscopy, results for chlamydial antibody tests correlated well with the severity of tubal inflammation and duration of lower abdominal pain, but chlamydiae were isolated from less than 40% of patients.3 Thus failure to isolate chlamydiae from the lower genital tract does not exclude these organisms as the causative agent. In these circumstances, given appropriate clinical indications, chlamydial antibody above a suitable cut off level might be a useful indicator of chlamydial infection. 18 Commercial kits are available for measuring chlamydial antibodies by ELISA or WIF. Microimmunofluorescence has been widely used as a diagnostic test for type specific chlamydial antibody20 and might provide useful confirmation of sera found positive by ELISA. Unfortunately, the microimmunofluorescence test is mainly restricted to research and reference laboratories. Moreover, the persistence of chlamydial antibodies following infec-tion and the possibility that infections with C psittaci and some other organisms might give rise to antibodies cross reactive with C trachomatis antigens means that caution is needed in interpreting the results of tests for chlamydial antibody on an individual patient. Improved methods of serological diagnosis for chlamydial pelvic inflammatory disease (PID) can be expected following detailed investigation of the antigenic specificity and persistence of human antibodies of different immunoglobulin class and subclass to chlamydiae. Meanwhile, although a diagnosis of chlamydial PID cannot be established with certainty by serology alone, a positive chlamydial antibody result by ELISA or immunofluorescence indicates the need for a more thorough investigation for chlamydial infection.
